GlaxoSmithKline Consumer Healthcare Ltd. - Research Center
500676 GSKCONS Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Dec' 19 |
Sep' 19 |
Jun' 19 |
Mar' 19 |
Dec' 18 |
Sales |
1,158.86 |
1,345.09 |
1,194.32 |
1,286.06 |
1,116.82 |
Operating profit |
272.08 |
395.81 |
280.40 |
318.48 |
238.53 |
Interest |
1.49 |
1.78 |
1.70 |
0.20 |
0.21 |
Gross profit |
386.63 |
472.16 |
405.28 |
441.17 |
362.57 |
EPS (Rs) |
65.77 |
82.10 |
58.98 |
67.95 |
52.56 |
Quarterly
results in details
|
Dec' 19 |
Sep' 19 |
Jun' 19 |
Mar' 19 |
Dec' 18 |
Other income |
116.04 |
78.13 |
126.58 |
122.89 |
124.25 |
Stock adjustment |
-22.17 |
-4.34 |
22.59 |
-0.10 |
-68.36 |
Raw material |
349.54 |
364.40 |
309.86 |
360.68 |
360.44 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
151.71 |
159.30 |
184.25 |
164.83 |
156.72 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
142.92 |
139.66 |
142.69 |
190.86 |
134.90 |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
264.78 |
290.26 |
254.53 |
251.31 |
294.59 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
19.17 |
20.33 |
19.62 |
14.92 |
15.81 |
Taxation |
90.83 |
106.52 |
137.58 |
140.44 |
125.70 |
Net profit / loss |
276.63 |
345.31 |
248.08 |
285.81 |
221.06 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
42.06 |
42.06 |
42.06 |
42.06 |
42.06 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
23.48 |
29.43 |
23.48 |
24.76 |
21.36 |
GPM (%) |
30.33 |
33.18 |
30.68 |
31.31 |
29.21 |
NPM (%) |
21.70 |
24.26 |
18.78 |
20.29 |
17.81 |